Patents : |  |
| US Patent No. | Title |
| 7608260 | Stabilized immunoglobulins
|
| 7611712 | Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide
|
| 7611729 | Dosage forms having prolonged active ingredient release
|
| 7611839 | Methods for diagnosing RCC and other solid tumors
|
| 7611879 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
|
| 7612039 | Method of cell growth inhibition with agnoprotein
|
| 7612044 | Melanoma antigens and their use in diagnostic and therapeutic methods
|
| 7612052 | Combinations comprising epothilones and pharmaceutical uses thereof
|
| 7612062 | Pyrrolobenzodiazepines
|
| 7612077 | Crystalline forms of the anti-cancer compound ZD1839
|
| 7612081 | 7-Polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups
|
| 7611711 | VEGFR-3 inhibitor materials and methods
|
| 7611704 | Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
|
| 7608739 | Mitotic kinesin inhibitors
|
| 7608264 | Antibodies that bind to pleiotrophin growth factor receptor
|
| 7608392 | Diagnostic assay for measuring a cell mediated immune response
|
| 7608394 | Methods and compositions for phenotype identification based on nucleic acid methylation
|
| 7608425 | Methods for protein expression in mammalian cells in serum-free medium
|
| 7608427 | Polynucleotide encoding an IL-28B polypeptide
|
| 7608428 | Polynucleotide encoding an IL-28B polypeptide
|
| 7608612 | Radiosensitizer formulations and methods for use
|
| 7608622 | Imidazo[4,5-b]pyrazinone inhibitors of protein kinases
|
| 7608635 | Pyrazole compounds that modulate HSP90 activity
|
| 7608643 | Compounds for inhibiting KSP kinesin activity
|
| 7612094 | Tri-substituted heteroaryls and methods of making and using the same
|
| 7612107 | Treatment and inhibition of disease conditions using flexible heteroarotinoids
|
| 7615628 | Imidazopyridine derivatives
|
| 7615632 | Crystalline forms of temozolomide
|
| 7615643 | Benzimidazole thiophene compounds
|
| 7618622 | Treatment of Parkinson's disease and related disorders using postpartum derived cells
|
| 7618633 | Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
|
| 7618781 | Nucleic acids for detecting B-cell malignancy
|
| 7618936 | Methods for treating and diagnosing cancer with WNT inhibitory Factor-1 (WIF-1)
|
| 7618971 | Mitotic kinesin inhibitors
|
| 7618981 | Imidazopyridinyl-benzamide anti-cancer agents
|
| 7618982 | Heteroarylpyrrolopyridinones active as kinase inhibitors
|
| 7615627 | RNA interference mediated inhibition of aurorakinase B and its combinations as anticancer therapy
|
| 7615554 | Erastin and erastin binding proteins, and uses thereof
|
| 7615379 | Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
|
| 7612162 | Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
|
| 7612172 | Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer
|
| 7612178 | Anti-IGF-1R antibodies and uses thereof
|
| 7612180 | Humanized L243 antibodies
|
| 7612202 | Process for preparing temozolomide
|
| 7615209 | Compositions of NDV and methods of use thereof for treatment of cancer
|
| 7615223 | Selected immunoconjugates for binding to aminophospholipids
|
| 7615229 | Mutants of the P4 protein of nontypable Haemophilus influenzae with reduced enzymatic activity
|
| 7615349 | Melanoma gene signature
|
| 7615353 | Tivozanib response prediction
|
| 7619006 | Conjugated psychotropic drugs and uses thereof
|
